PASO ROBLES, California, February 6, 2018 /PRNewswire/ --
NCM Biotech is the for-profit outgrowth of Natures Comfort Meds, a not-for-profit research organization dedicated to discovering and developing solutions to medical issues through the use of the cannabis plant and its oils. With a scientific advisory team that includes, Dr. John Gaitanis, Pediatric Neurologist at Tufts Medical Center/Floating Hospital for Children and Dr. Lloyd Saberski, Anesthesiologist/Pain Management Specialist practicing at Yale New Haven Medical Center, NCM maintains research partnerships for live genomics testing with Brown University and Beech Tree Labs.
NCM recently completed successful tests of Greenbelt's bioethanol for use as a solvent during the extraction process. Greenbelt produced the bioethanol from brewery waste collected in its hometown of Paso Robles, California. Brewery waste, along with other local waste-based feedstocks, is targeted for use in Greenbelt's Commercial Scale Feedstock Testing Facility, currently under development and expected to be in production by the end of 2018.
The LOI expresses the intention of the two companies to combine their respective resources and build and operate extraction testing services based in Oregon and in Greenbelt's facility in California.
According to Forbes, medical cannabis sales are projected to grow from $4.7 billion in 2016 to $13.3 billion in 2020.
About NCM Biotechnology Natures Comfort Meds Biotechnology (NCM Biotech) is dedicated to the research and development of cannabis oil for the treatment of various illnesses, diseases and chronic pain as a symptom of various diagnoses. Our unique and industry leading medicine has a patented extraction process, which results in the highest quality oil with levels of CBD much higher than any other leading competitor. It is because of this patented process, we are able to build a foundation of research and clinical process that allows our company to procure strategic partnerships and further expand our capabilities nationwide. For more information visit http://www.ncmbiotech.com.
About Greenbelt Resources
Greenbelt Resources Corporation™ is an award-winning provider of sustainable energy production systems focused on delivering modular solutions that enable the localized processing of locally generated waste into locally consumed products. Greenbelt designs, develops and implements technology that makes the production of advanced biofuel reliable, practical and efficient. Controlled by proprietary automated controls, Greenbelt's small-scale, end-to-end modular systems convert food, beverage and other cellulosic wastes into commercially viable advanced biofuels (bio-ethanol), animal feed, fertilizer and filtered water. For more information visit http://www.greenbeltresources.com.
Forward-Looking Statements & Safe Harbor
This document includes certain statements, predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the supply and demand for biofuels, our ability to remain technologically competitive and other economic, competitive and technological factors involving the Company's operations, markets, services, products and prices.
Contact: Darren Eng, CEO Greenbelt Resources Corporation +1-888-995-GRCO (4726 x 101) [email protected]
SOURCE Greenbelt Resources Corporation
Advertisement
NCM Biotech (NCM) and Greenbelt Resources Corporation (OTC: GRCO) (Greenbelt) today announced they are entering into a Letter of Intent (LOI) to jointly develop and operate a cannabis extraction testing service with facilities in California and Oregon. When operational, the facilities will serve the global medical cannabis market. NCM Biotech has a process, patented in 2016, for extracting cannabinoids from the cannabis plant.
Advertisement
NCM Biotech is the for-profit outgrowth of Natures Comfort Meds, a not-for-profit research organization dedicated to discovering and developing solutions to medical issues through the use of the cannabis plant and its oils. With a scientific advisory team that includes, Dr. John Gaitanis, Pediatric Neurologist at Tufts Medical Center/Floating Hospital for Children and Dr. Lloyd Saberski, Anesthesiologist/Pain Management Specialist practicing at Yale New Haven Medical Center, NCM maintains research partnerships for live genomics testing with Brown University and Beech Tree Labs.
NCM recently completed successful tests of Greenbelt's bioethanol for use as a solvent during the extraction process. Greenbelt produced the bioethanol from brewery waste collected in its hometown of Paso Robles, California. Brewery waste, along with other local waste-based feedstocks, is targeted for use in Greenbelt's Commercial Scale Feedstock Testing Facility, currently under development and expected to be in production by the end of 2018.
The LOI expresses the intention of the two companies to combine their respective resources and build and operate extraction testing services based in Oregon and in Greenbelt's facility in California.
According to Forbes, medical cannabis sales are projected to grow from $4.7 billion in 2016 to $13.3 billion in 2020.
About NCM Biotechnology Natures Comfort Meds Biotechnology (NCM Biotech) is dedicated to the research and development of cannabis oil for the treatment of various illnesses, diseases and chronic pain as a symptom of various diagnoses. Our unique and industry leading medicine has a patented extraction process, which results in the highest quality oil with levels of CBD much higher than any other leading competitor. It is because of this patented process, we are able to build a foundation of research and clinical process that allows our company to procure strategic partnerships and further expand our capabilities nationwide. For more information visit http://www.ncmbiotech.com.
About Greenbelt Resources
Greenbelt Resources Corporation™ is an award-winning provider of sustainable energy production systems focused on delivering modular solutions that enable the localized processing of locally generated waste into locally consumed products. Greenbelt designs, develops and implements technology that makes the production of advanced biofuel reliable, practical and efficient. Controlled by proprietary automated controls, Greenbelt's small-scale, end-to-end modular systems convert food, beverage and other cellulosic wastes into commercially viable advanced biofuels (bio-ethanol), animal feed, fertilizer and filtered water. For more information visit http://www.greenbeltresources.com.
Forward-Looking Statements & Safe Harbor
This document includes certain statements, predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the supply and demand for biofuels, our ability to remain technologically competitive and other economic, competitive and technological factors involving the Company's operations, markets, services, products and prices.
Contact: Darren Eng, CEO Greenbelt Resources Corporation +1-888-995-GRCO (4726 x 101) [email protected]
SOURCE Greenbelt Resources Corporation
